Brinker Capital Investments, LLC Exelixis, Inc. Transaction History

Brinker Capital Investments, LLC

$11.4 Billion
Q3 2025

A detailed history of Brinker Capital Investments, LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Brinker Capital Investments, LLC holds 55,926 shares of EXEL stock, worth $2.33 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

55,926

Previous 55,301 1.13%

Holding current value

$2.33 Million

Previous $2.44 Million 5.25%

% of portfolio

0.02%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	BUY	$36.22 - $46.25 $22,637 - $28,906	625 Added 1.13%	55,926 $2.31 Million
Q2 2025 Aug 14, 2025	BUY	$34.13 - $46.26 $314,815 - $426,702	9,224 Added 20.02%	55,301 $2.44 Million
Q1 2025 Jul 31, 2025	SELL	$32.38 - $39.16 $241,263 - $291,781	-7,451 Reduced 13.92%	46,077 $1.7 Million
Q4 2024 Jul 31, 2025	SELL	$25.39 - $36.46 $145,459 - $208,879	-5,729 Reduced 9.67%	53,528 $1.78 Million
Q3 2024 Jul 31, 2025	SELL	$21.96 - $27.6 $153 - $193	-7 Reduced 0.01%	59,257 $1.54 Million

Q2 2024 Jul 31, 2025	BUY	$20.34 - $23.73 $119,599 - $139,532	5,880 Added 11.01%	59,264 $1.33 Million
Q1 2024 Jul 31, 2025	SELL	$20.17 - $23.93 $57,726 - $68,487	-2,862 Reduced 5.09%	53,384 $1.27 Million
Q4 2023 Jul 31, 2025	SELL	$19.25 - $24.13 $69,473 - $87,085	-3,609 Reduced 6.03%	56,246 $1.35 Million
Q3 2023 Jul 31, 2025	SELL	$19.04 - $22.74 $67,401 - $80,499	-3,540 Reduced 5.58%	59,855 $1.31 Million
Q2 2023 Jul 31, 2025	SELL	$18.17 - $20.48 $39,501 - $44,523	-2,174 Reduced 3.32%	63,395 $1.21 Million
Q1 2023 Jul 31, 2025	SELL	$16.3 - $19.41 $1.32 Million - $1.57 Million	-81,036 Reduced 55.28%	65,569 $1.27 Million
Q4 2022 Feb 06, 2023	BUY	$14.96 - $17.39 $114,758 - $133,398	7,671 Added 5.52%	146,605 $2.35 Million
Q3 2022 Nov 01, 2022	SELL	$15.68 - $22.27 $44,013 - $62,511	-2,807 Reduced 1.98%	138,934 $2.18 Million
Q2 2022 Jul 18, 2022	SELL	$17.44 - $23.16 $109,436 - $145,329	-6,275 Reduced 4.24%	141,741 $2.95 Million
Q1 2022 May 16, 2022	BUY	$17.03 - $22.67 $205,994 - $274,216	12,096 Added 8.9%	148,016 $3.36 Million
Q4 2021 Feb 08, 2022	BUY	$15.84 - $21.88 $314,772 - $434,799	19,872 Added 17.12%	135,920 $2.49 Million
Q2 2021 Aug 03, 2021	BUY	$17.95 - $25.56 $265,857 - $378,569	14,811 Added 14.63%	116,048 $2.11 Million
Q1 2021 May 12, 2021	SELL	$20.53 - $25.22 $794,654 - $976,190	-38,707 Reduced 27.66%	101,237 $2.29 Million
Q4 2020 Feb 16, 2021	BUY	$18.39 - $24.8 $998,705 - $1.35 Million	54,307 Added 63.42%	139,944 $2.81 Million
Q3 2020 Dec 03, 2020	BUY	$20.67 - $26.94 $1.77 Million - $2.31 Million	85,637 New	85,637 $2.09 Million

Others Institutions Holding EXEL

# of Institutions

700

Shares Held

258M

Call Options Held

1.5M

Put Options Held

1.71M

View Full List

About EXELIXIS, INC.

Ticker EXEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 321,832,000
Market Cap $13.4B
Description
Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...

More about EXEL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brinker Capital Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brinker Capital Investments, LLC with notifications on news.

Account

Brinker Capital Investments, LLC Exelixis, Inc. Transaction History